
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines | 300.43 | 136.35 | 83.10% |
| Name | Price | % Change | |
|---|---|---|---|
| $300.43 | +83.10% |

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by

JPMorgan analyst Tessa Romero raised the firm’s price target on Praxis Precision (PRAX) to $725 from $700 and keeps an Overweight rating on the shares. JPMorgan also added Praxis to

B. Riley initiated coverage of Praxis Precision (PRAX) with a Buy rating and $713 price target over two-times current share levels. Within 10 weeks, Praxis could evolve from clinical to

Aurora Innovation ($AUR), SanDisk Corp. ($SNDK), and Praxis Precision Medicines ($PRAX) are three high-risk, high-reward stocks analysts see as having massive upside potential. Wall Street rates each a Strong Buy

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by

Wells Fargo analyst Benjamin Burnett upgraded Praxis Precision (PRAX) to Overweight from Equal Weight with a price target of $509, up from $343. Following the investor day, the firm is

Guggenheim lowered the firm’s price target on Praxis Precision (PRAX) to $1,050 from $8,000 and keeps a Buy rating on the shares. At its investor day, Praxis laid out a

Baird raised the firm’s price target on Praxis Precision (PRAX) to $568 from $514 and keeps an Outperform rating on the shares. The firm updated its model following its Investor

Praxis Precision Medicines ( ($PRAX) ) just unveiled an update. On November 12, 2026, Praxis Precision Medicines hosted an Investor Day covering commercial strategy and launch plans for ulixacaltamide in

Wells Fargo lowered the firm’s price target on Praxis Precision (PRAX) to $343 from $362 and keeps an Equal Weight rating on the shares. The firm thinks the bull/bear debate
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Initiated | Nov 20, 2026 | ||||
| buy | Assigned | Nov 20, 2026 | ||||
| buy | Reiterated | Nov 17, 2026 | ||||
| buy | Upgraded | Nov 17, 2026 | ||||
| buy | Reiterated | Nov 16, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 13, 2026 | ||||
| buy | Reiterated | Nov 12, 2026 | ||||
| buy | Assigned | Nov 10, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 3, 2027TBA | $8.69B | $-4.08 | $348.00K | -0.68 | -24.25 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.